Valiant Laborato

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0JWS01017
  • NSEID: VALIANTLAB
  • BSEID: 543998
INR
99.20
-2 (-1.98%)
BSENSE

Nov 20

BSE+NSE Vol: 1.06 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Valiant Laborato
Trident Lifeline
Anuh Pharma
Haleos Labs Limi
Shree Ganesh Rem
Zim Laboratories
Wanbury
Transchem
Ennature Bio Pha
Influx Health.
Infinium Pharma
Why is Valiant Laboratories Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0 times
2
With a growth in Operating Profit of 461.7%, the company declared Very Positive results in Sep 26
  • The company has declared positive results for the last 3 consecutive quarters
  • PAT(Latest six months) Higher at Rs 21.51 cr
  • ROCE(HY) Highest at 7.74%
  • NET SALES(Q) Highest at Rs 116.77 cr
3
Stock is technically in a Mildly Bullish range
  • The stocks Bollinger Band and DOW technical factors are also Mildly Bullish
4
With ROE of 4.9, it has a Attractive valuation with a 1.6 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 28.50%, its profits have risen by 219.7% ; the PEG ratio of the company is 0.2
5
Market Beating Performance
  • The stock has generated a return of 28.50% in the last 1 year, much higher than market (BSE500) returns of 0.37%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Valiant Laborato should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Valiant Laborato for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Valiant Laborato
28.5%
0.49
57.77%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
11.49%
EBIT Growth (5y)
11.87%
EBIT to Interest (avg)
2.29
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.73
Tax Ratio
34.95%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.15%
ROCE (avg)
0.65%
ROE (avg)
2.16%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
33
Industry P/E
40
Price to Book Value
1.62
EV to EBIT
20.10
EV to EBITDA
14.07
EV to Capital Employed
1.62
EV to Sales
1.43
PEG Ratio
0.15
Dividend Yield
NA
ROCE (Latest)
8.06%
ROE (Latest)
4.88%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

26What is working for the Company
PAT(Latest six months)

Higher at Rs 21.51 cr

ROCE(HY)

Highest at 7.74%

NET SALES(Q)

Highest at Rs 116.77 cr

-6What is not working for the Company
PBT LESS OI(Q)

At Rs 0.56 cr has Fallen at -89.8% (vs previous 4Q average

PAT(Q)

At Rs 0.41 cr has Fallen at -89.8% (vs previous 4Q average

Loading Valuation Snapshot...
Here's what is working for Valiant Laborato
Net Sales - Quarterly
Highest at Rs 116.77 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 116.77 cr has Grown at 52.7% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 76.48 Cr
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Here's what is not working for Valiant Laborato
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 0.56 cr has Fallen at -89.8% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 5.50 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 0.41 cr has Fallen at -89.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 4.00 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)